Heart Flashcards
preload
Preload is the initial stretching of the cardiac myocytes (muscle cells) prior to contraction
4 things that increase stroke volume e
Cardiac size, contractility, preload and afterload are the 4 factors affecting stroke volume
Increased central venous pressure would increase venous return, hence increasing preload.
B-type natriuretic peptide (BNP) is a hormone produced mainly by the left ventricular myocardium in response to
strain
Whilst heart failure is the most obvious cause of raised BNP levels any cause of left ventricular dysfunction such as myocardial ischaemia or valvular disease may raise levels. Raised levels may also be seen due to reduced excretion in patients with chronic kidney disease. Factors which reduce BNP levels include treatment with ACE inhibitors, angiotensin-2 receptor blockers and diuretics.
Effects of BNP
vasodilator
diuretic and natriuretic
suppresses both sympathetic tone and the renin-angiotensin-aldosterone system
4 uses of BNP
Diagnosing patients with acute dyspnoea
a low concentration of BNP(< 100pg/ml) makes a diagnosis of heart failure unlikely, but raised levels should prompt further investigation to confirm the diagnosis
NICE currently recommends BNP as a helpful test to rule out a diagnosis of heart failure
Prognosis in patients with chronic heart failure
initial evidence suggests BNP is an extremely useful marker of prognosis
Guiding treatment in patients with chronic heart failure
effective treatment lowers BNP levels
Screening for cardiac dysfunction
not currently recommended for population screening
Varicose veins are dilated, tortuous, superficial veins that occur secondary to incompetent venous valves, allowing blood to flow back, away from the heart. They most commonly occur in the legs due to reflux in the great saphenous vein and small saphenous vein. Whilst extremely common, the vast majority of patients do not require any intervention.
risk factors
ncreasing age female gender pregnancy the uterus causes compression of the pelvic veins obesity
symtpoms
aching
throbbing
tihing
complications of varicose viens
Other patients may present with complications of varicose veins:
a variety of skin changes may be seen:
varicose eczema (also known as venous stasis)
haemosiderin deposition → hyperpigmentation
lipodermatosclerosis → hard/tight skin
atrophie blanche → hypopigmentation
bleeding
superficial thrombophlebitis
venous ulceration
deep vein thrombosis
A 2-month-old baby is diagnosed with a ventricular septal defect. This is due to a failure in embryological development of which cardiovascular structure?
endocardial sinus
Development of the heart begins at about day 18 in the embryo from the mesoderm from a group of cells from the cardiogenic area. Signals from the underlying endoderm result in the formation of a pair of elongated strands known as the cardiogenic cords. These cords fuse together resulting in the primitive heart tube.
At day 22, there is the development of five regions in the primitive heart tube: beginning superiorly, the 1) truncus arteriosus, 2) bulbus cordis, 3) primitive ventricle, 4) primitive atrium and the 5) sinus venosus. These later become the 1) ascending aorta and pulmonary trunk, 2) right ventricle, 3) left ventricle, 4) anterior atrial walls and appendages, and the 5) coronary sinus and sino-atrial node respectively.
Over the next week, the embryo’s heart undergoes morphogenesis where it loops and twists from a vertical tube into the premature heart with atrial and ventricular orientation present by day 28. Thickenings of mesoderm in the inner lining of the heart walls (called endocardial cushions) appear and grow towards each other. They fuse and divide the atrioventricular canal into left and right sides. Failure of the endocardial cushions to develop properly will result in a ventricular septal defect.
By the end of the 5th week, the four heart chamber positions are complete. The atrioventricular and semilunar valves form between the 5th and 9th weeks.
failure of endocardial cushions to develop rest in what
ventricular septal defect
Aetiology of VSD ( ventricular septal defects)
congenital VSDs are often association with chromosomal disorders Down's syndrome Edward's syndrome Patau syndrome cri-du-chat syndrome congenital infections acquired causes post-myocardial infarction
pan systolic mumur which is louder in smaller defects
management of VSD
small VSDs which are asymptomatic often close spontaneously are simply require monitoring
moderate to large VSDs usually result in a degree of heart failure in the first few months
nutritional support
medication for heart failure e.g. diuretics
surgical closure of the defect
left ventricular ejection fraction =
stroke volume/end diastolic LV volume
stroke volume = end diastolic volume - ends systolic volume
systemic vascular resistance =
mean arterial pressure/cardiac output
A teenage boy collapses while playing tennis and is pronounced dead in hospital. The post-mortem reveals heart abnormalities. What is the most likely abnormality?
hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy is the only condition listed above that typically presents with sudden death, which rules out the other options.
Acute myocarditis may present with chest pain, fever, palpitations, tachycardia and dyspnoea.
Dilated cardiomyopathy may present with right ventricular failure, dyspnoea, pulmonary oedema, and atrial fibrillation.
Restrictive cardiomyopathy presents similarly to constrictive pericarditis, where right heart failure signs predominate: raised JVP, hepatomegaly, oedema, ascites.
Atrial myxoma may present with dizziness, fainting and palpitations, due to obstruction of the conductive pathway.
Hypertrophic cardiomyopathy (HCM)
HCM results in obstruction of the left ventricular outflow tract due to asymmetric septal hypertrophy.
signs and symptoms
sudden death; angina, dyspnoea, palpitations, syncope.
typically following exercise
double apex beat
Tests: ECG (will show high Q waves due to left ventricular hypertrophy), echocardiogram (shows hypertrophy)
treatment
Treatment: bed rest, diuretics, digoxin, ACE-inhibitors, anticoagulation, biventricular pacing, implantable cardioverter-defibrillator, cardiac transplantation